The MOMENTUM Routine Immunization Transformation and Equity project is part of a suite of innovative awards funded by the U.S. Agency for International Development (USAID) to holistically improve family planning and maternal and child health in partner countries around the world. The project applies best practices and explores innovations to increase equitable immunization coverage in USAID-supported countries around the globe. It works to build countries’ capacity to identify and overcome barriers to reaching zero-dose and under-immunized children and older populations with life-saving vaccines and other integrated health services. The project also contributes to ongoing global efforts to mitigate the impact of COVID-19 on immunization services and support countries to prepare for and introduce COVID-19 vaccines. MOMENTUM Routine Immunization Transformation and Equity works at multiple levels and in alignment with global strategies such as the Immunization Agenda 2030 and Gavi 5.0.
MOMENTUM Routine Immunization Transformation and Equity is currently engaged to help national roll-out of COVID-19 vaccine in eighteen countries worldwide. We support national-level government activities and provide technical support at sub-national levels as well. Activities center around planning and coordination, supply chain, health worker capacity building, demand generation/community engagement, and data/monitoring and evaluation.
To strengthen routine immunization in key countries, MOMENTUM Routine Immunization Transformation and Equity is using a co-creation process to identify and implement approaches to address entrenched obstacles to reaching zero-dose children with vaccines. To date, MOMENTUM is focused on routine immunization in the DRC, Mozambique, Kenya, India, and Nigeria.
The project was awarded to JSI Research & Training Institute Inc., and their sub-partners PATH, Accenture Development Partnerships, Results for Development, Gobee Group, CORE Group, and The Manoff Group. The consortium brings a track record in shaping global direction, and will collaborate with local partners to improve immunization outcomes and build on the accomplishments and learnings.